Business Standard

Covid-19 crisis: Normal life back likely next winter, says BioNTech CEO

BioNTech co-founder Uğur Şahin told BBC One's The Andrew Marr Show on Sunday: "this winter will be hard and the vaccine will not have a big impact on the infection numbers

Ugur Sahin, BioNTech co-founder
Premium

Ugur Sahin, BioNTech co-founder

Agencies Mainz (Germany)
The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials and has been found to be 90 per cent effective said that “if everything continues to go well…we could have a normal winter next year.

BioNTech co-founder UgurSahintold BBC One’s The Andrew Marr Show on Sunday: “this winter will be hard and the vaccine will not have a big impact on the infection numbers. But he said that if everything continues to go well, the goal is to deliver more than 300 million doses of the vaccine before April next year, which could allow us to already start

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in